Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3,4-Dihydroxybenzeneacetic acid (3,4-Dihydroxyphenylacetic acid) is the main metabolite of dopamine.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
100 mg | 在庫あり | ¥ 10,000 | |||
500 mg | 在庫あり | ¥ 21,500 | |||
1 g | 在庫あり | ¥ 30,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 7,000 |
説明 | 3,4-Dihydroxybenzeneacetic acid (3,4-Dihydroxyphenylacetic acid) is the main metabolite of dopamine. |
In vitro | Cerebrospinal fluid (CSF) 3,4-Dihydroxybenzeneacetic acid (DOPAC) is derived from the intra-neuronal metabolism of cytoplasmic dopamine and acts as a sensitive and specific biomarker of central dopamine deficiency[1]. |
別名 | DOPAC, 3,4-Dihydroxyphenylacetic acid |
分子量 | 168.15 |
分子式 | C8H8O4 |
CAS No. | 102-32-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mg/mL
DMSO: 50 mg/mL (297.35 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3,4-Dihydroxybenzeneacetic acid 102-32-9 Metabolism Endogenous Metabolite 3,4Dihydroxybenzeneacetic acid inhibit DOPAC 3,4 Dihydroxybenzeneacetic acid 3,4-Dihydroxyphenylacetic acid Inhibitor inhibitor